Amanote Research

Amanote Research

    RegisterSign In

Effects of Angiotensin-Converting Enzyme Inhibitors on Central Blood Pressure

Hypertension - United States
doi 10.1161/hypertensionaha.107.095646
Full Text
Open PDF
Abstract

Available in full text

Categories
Internal Medicine
Date

September 1, 2007

Authors
Michael F. O’RourkeWilmer W. NicholsMichel E. Safar
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search

Angiotensin Converting Enzyme (ACE) Inhibitors

Annual Review of Pharmacology and Toxicology
ToxicologyPharmacology
1982English

Dosage of Angiotensin Converting Enzyme Inhibitors

BMJ
1995English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Angiotensin Converting Enzyme Inhibitors for Cancer Treatment?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2004English

Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.

BMJ
1992English

N-Protected Tripeptide Inhibitors of Angiotensin Converting Enzyme.

Agricultural and Biological Chemistry
1990English

Angioedema, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blocking Drugs

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2007English

Marketing Research on the Angiotensin-Converting Enzyme Inhibitors Antihypertensive Medicines

Medicine and Pharmacy Reports
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy